Showing results (91-100 of 433) with videos related to
Sort By:
Pageof 44
Journal of the Endocrine Society|October 31, 2024
Population-Based Study of Rare Coding Variants in NR5A1/SF-1Chrysanthi Kouri, Raina Y Jia, Katherine A Kentistou, et al.The Journal of Clinical Endocrinology and Metabolism|October 3, 2021
Serum Estradiol and 20 Site-Specific Cancers in Women: Mendelian Randomization StudySusanna C Larsson, Siddhartha Kar, John R B Perry, et al.Diabetes|October 27, 2004
Common variants of the hepatocyte nuclear factor-4alpha P2 promoter are associated with type 2 diabetes in the U.K. populationMichael N Weedon, Katharine R Owen, Beverley Shields, et al.Human Molecular Genetics|July 16, 2021
Higher adiposity and mental health: causal inference using Mendelian randomizationFrancesco Casanova, Jessica O'Loughlin, Susan Martin, et al.BMC Medical Genetics|May 13, 2010
Large-scale association analysis of TNF/LTA gene region polymorphisms in type 2 diabetesVesna Boraska, Nigel W Rayner, Christopher J Groves, et al.Human Molecular Genetics|November 8, 2014
Whole-genome sequencing to understand the genetic architecture of common gene expression and biomarker phenotypesAndrew R Wood, Marcus A Tuke, Mike Nalls, et al.Journal of Medical Genetics|August 29, 2024
Protein-truncating and rare missense variants in ATM and CHEK2 and associations with cancer in UK Biobank whole-exome sequence dataToqir K Mukhtar, Naomi Wilcox, Joe Dennis, et al.Human Molecular Genetics|October 21, 2019
A genome-wide association study implicates multiple mechanisms influencing raised urinary albumin-creatinine ratioFrancesco Casanova, Jessica Tyrrell, Robin N Beaumont, et al.Diabetes|July 29, 2006
Assessment of the role of common genetic variation in the transient neonatal diabetes mellitus (TNDM) region in type 2 diabetes: a comparative genomic and tagging single nucleotide polymorphism approachAnna L Gloyn, Deborah J G Mackay, Michael N Weedon, et al.Human Molecular Genetics|September 1, 2022
Genetically proxied therapeutic prolyl-hydroxylase inhibition and cardiovascular riskCharli E Harlow, Vickas V Patel, Dawn M Waterworth, et al.Pageof 44